Home > Journals > Biology and research > Magnesium Research > Full text
 
      Advanced search    Shopping cart    French version 
 
Latest books
Catalogue/Search
Collections
All journals
Medicine
Biology and research
Magnesium Research
- Current issue
- Archives
- Subscribe
- Order an issue
- More information
Public health
Agronomy and biotech.
My account
Forgotten password?
Online account   activation
Subscribe
Licences IP
- Instructions for use
- Estimate request form
- Licence agreement
Order an issue
Pay-per-view articles
Newsletters
How can I publish?
Journals
Books
Help for advertisers
Foreign rights
Book sales agents



 

Texte intégral de l'article
 
  Printable version
  Version PDF

Concentration, compartmentation and metabolic function of intracellular free Mg 2+


Magnesium Research. Volume 19, Number 4, 225-36, December 2006, Review article

DOI : 10.1684/mrh.2006.0067

Summary  

Author(s) : T Günther , Charité–Universitätsmedizin Berlin, Campus Benjamin Franklin, Institut für Molekularbiologie und Biochemie, Arnimallee 22, 14195 Berlin, Germany.

Summary : Intracellular total Mg 2+ and free Mg 2+ are compartmentalized between cell organelles and within the cytosol. Different values of [Mg 2+] i in the cytosol of the same cell type were measured by various investigators. A main reason for the differences is the uncertainty of the dissociation constants used for the Mg furaptra complex in the fluorescence method and for MgATP when 31P NMR was employed. The more realistic K D values of Mg furaptra and MgATP measured under in situ conditions are higher than the K Ds used by most investigators. The [Mg 2+] is obtained and the K Ds used by various authors were presented. The role of intracellular Mg 2+ in metabolic functions and the action of various effectors on [Mg 2+] i and [Ca 2+] i was reviewed. Intracellular Mg 2+ may have a permissive role supporting the effector-induced mechanisms that are mediated by Ca 2+ as a second messenger.

Keywords : [Mg 2+] i [Ca 2+] i [Na +] i, concentration of intracellular free Mg 2+, free Ca 2+ and Na +, [Mg 2+] o, concentration of extracellular Mg 2+, K D, dissociation constant, K A, association constant, K M, Michaelis constant, 31P NMR, 31-phosphorus nuclear magnetic resonance, pMg, -log [Mg 2+], TEABr, tetraethylammonium bromide, VSMC, vascular smooth muscle cells, MDCK, Madin-Darby canine kidney, CTAL, cortical thick ascending limb, ANP, atrial natriuretic peptide, PTH, parathyroid hormone, PHA-L, phytohaemagglutinin-L, ConA, concanavalin A, EGF, epidermal growth factor, AVP, arginine vasopressin

ARTICLE

Auteur(s) : T Günther

Charité–Universitätsmedizin Berlin, Campus Benjamin Franklin, Institut für Molekularbiologie und Biochemie, Arnimallee 22, 14195 Berlin, Germany

Compartmentation of intracellular Mg2+

Only 1% of total body Mg2+ (about 1 mole) is localized in the extracellular fluid. Of the remainder, 50-60% are adsorbed to hydroxyapatite crystals of bone and 40-50% are localized intracellularly. Hence, Mg2+ is an intracellular cation. Total intracellular Mg2+ in various cell types and tissues amounts to 3-9 mmol/kg wet weight [1]. Due to Mg2+ binding to DNA, nucleus-containing cells have a higher Mg2+ content than unnucleated cells. Rapidly growing cells have a higher Mg2+ content than slowly growing cells due to their higher content of ribosomes and thus Mg2+ bound to rRNA.

In context with these facts, intracellular Mg2+ is compartmentalized. The percentage of Mg2+ localized in nuclei, mitochondria, microsomes (ribosomes) and cytosol is shown in table 1( Table 1 ). The differences found by various investigators are probably caused by a different intensity in tissue homogenisation. For a detailed discussion, see [1, 2]. These values are based on the total Mg2+ contents and include bound Mg2+ and free Mg2+. [Mg2+]i in a cellular compartment depends on total Mg2+, on the concentration of Mg2+-binding substances, on their Mg2+ affinity, and on the Mg2+ transport activity of the membranes.
Table 1 Subcellular distribution of Mg2+ in rat liver. Values provided by 3 different investigators in % of total Mg2+ were taken from [1, 2].

1

2

3

Nuclei

13.4

16.3

47.8

Mitochondria

21.8

23.2

17.4

Microsomes

48.0

45.2

13.7

Cytosol

12.8

14.1

19.2

Determination of [Mg2+]i

Methods to measure [Mg2+]i are based on Mg2+-binding fluorescent indicators, e.g. furaptra, also called mag-fura-2, 31P NMR and Mg2+-sensitive microelectrodes. In some cases null-point and enzymatic methods were used. For a review see [3-5].

Furaptra

In this method, [Mg2+]i is determined according to:

Rmin and Rmax are the excitation wave length ratios at 335/370 nm for uncomplexed (excess EDTA) and Mg2+-saturated furaptra respectively. Sf and Sb are the fluorescence intensities measured at the 370 nm excitation wave length for furaptra with excess EDTA and excess Mg2+ respectively. R is the excitation ratio at 335/370 nm of the sample to be measured. For KD of the Mg furaptra complex, usually a value of 1.5 mM was used. For uncertainty of KD see below.

31P NMR

Many investigators have determined [Mg2+]i according to:where ø is usually calculated from the chemical shift differences of the α and β phosphorus peaks of ATP due to binding of Mg2+. Some investigators also used other formulae to determine [Mg2+]i from 31P NMR measurements. For details see [6].

KDMgATP represents the dissociation constant of the MgATP complex. KDMgATP values have been measured for more than 50 years. A selection of these values is listed in table 2A( Table 2 ). More values for KDMgATP are shown in table 3( Table 3 ). Also, when measured by various investigators under identical conditions of temperature, pH and ionic strength, the values measured for KD of MgATP show great variability.
Table 2 A) Various values of the dissociation constant (KD) of the MgATP complex as published by various authors. Values for log KA (association constant) from [12] were calculated as KD for comparison with the values provided by other authors.B) Dissociation constant of MgATP (KD) as a function of pH and temperature according to [14, 20].C) Dissociation constant of MgATP (KD) as a function of ionic strength at 25 °C and pH 7.2 according to [14].

A)

T (°C)

pH

Ionic strength (M)

KD (μM)

Ref.

20

0.1 KCl

144

[12]

25

0.1 KCl

91.2

[12]

25

0.1 KCl

56.2

[12]

25

0.1 TEABr

42.6

[12]

30

0.1 TEABr

9.6

[12]

25

7.0

0.1 TEABr

37.4

[13]

25

7.2

0.14 KCl, 0.014 NaCl

127.5

[14]

25

7.2

0.14 KCl, 0.01 NaCl

45

[15]

37

7.2

0.13 KCl, 0.02 NaCl

83.3

[16]

37

7.2

0.14 KCl, 0.014 NaCl

87.4

[14]

37

7.2

0.15 KCl

38

[17]

37

7.2

0.15 KCl

46

[18]

B)

KD (μM)

pH

25° C

37° C

6.7

157.0

106.6

7.2

127.5

87.4

7.7

101.0

78.1

C)

Ionic strength (M)

KD (μM)

0.087

61.9

0.156 

243.0

0.300

127.5


Table 3 Concentration of intracellular free Mg2+ ([Mg2+]i) in various cell types and tissues as measured with various methods. The used dissociation constants of Mgfuraptra and MgATP as well as the used Mg2+ sensor in the Mg2+ electrodes were listed.

Cells / Tissue

Method

KD

[Mg2+]i (mM)

Ref.

Frog muscle fibers

Furaptra

4.6 mM

1.7

[21]

Chicken cardiomyocytes

Furaptra

1.5 mM

0.48

[22]

Rat hepatocytes

Furaptra

1.5 mM

0.59

[23]

VSMC

Furaptra

1.5 mM

0.48

[24]

Guinea pig tenia cecum

Furaptra

5.4 mM

0.98

[25]

A7r5 cells

Furaptra

5.4 mM

0.74

[25]

A7r5 cells

Furaptra

1.5 mM

0.31

[26]

Rat cardiomyocytes

Furaptra

5.4 mM

1.13

[25]

Rat cardiomyocytes

Furaptra

5.3 mM

0.91

[27]

BC3H-1 cells (fibroblasts)

Furaptra

1.58 mM

0.54

[28]

Pancreatic acinar cells

Furaptra

1.5 mM

1.39

[29]

Human lymphocytes

Furaptra

2.1 mM

0.24

[30]

Mouse skeletal muscle

Mag-indo-1

5.1 mM

1.53

[31]

Rat erythrocytes

31P NMR

44.3 μM

0.193

[11]

Human erythrocytes

31P NMR

38 μM

0.223

[32]

Human erythrocytes

31P NMR

50 μM

0.225

[33]

Human erythrocytes

Null-point

0.4

[34]

Rat erythrocytes

Null-point

0.38

[35]

Rat brain

31P NMR

44.3 μM

0.47

[11]

Rat brain

31P NMR

90 μM

0.56

[36]

Guinea pig brain

31P NMR

86 μM

0.33

[37]

Human brain

31P NMR

20.6 μM

0.32

[38]

Human brain

31P NMR

44.3 μM

0.35

[11]

Rat liver

31P NMR

86 μM

0.7

[39]

Rat liver

31P NMR

50 μM

0.8

[40]

Rabbit uterus

31P NMR

29 μM

0.4

[41]

Human skeletal muscle

31P NMR

50 μM

0.557

[42]

Human skeletal muscle

31P NMR

44.3 μM

0.47

[11]

Guinea pig heart

31P NMR

28.7 μM

2.5

[43]

Frog skeletal muscle

31P NMR

45 μM

0.6

[44]

Guinea pig tenia cecum

31P NMR

41 μM

0.33

[45]

Ascites tumor cells

31P NMR

60 μM

0.44

[46]

Human platelets

31P NMR

38 μM

0.23

[47]

Human platelets

Null-point

0.3

[47]

Mouse lymphocytes

Null-point

0.9

[48]

Mouse lymphocytes

Mg2+ electrode ETH1117

1.35

[48]

Frog skeletal muscle

Mg2+ microelectr. ETH1117

3.8

[49]

Frog skeletal muscle

Mg2+ microelectr. ETH1117

3.3

[50]

Frog skeletal muscle

Mg2+ microelectr. ETH1117

1.3

[51]

Rat skeletal muscle

Mg2+ microelectr. ETH1117

0.47

[52]

Guinea pig heart

Mg2+ microelectr. ETH5214

0.72

[53]

Ferret myocard

Mg2+ microelectr. ETH5214

0.85

[54]

Ferret myocard

Mg2+ microelectr. ETH1117

3.0

[50]

Pancreatic acinar cells

Mg2+ microelectr. ETH5214

0.58

[55]

Snail neurones

Mg2+ microelectr. ETH1117

0.66

[56]

Mg2+-sensitive microelectrodes

Mg2+-sensitive microelectrodes are based on the neutral ionophores ETH 1117 or on the more specific derivative ETH 5214 with less K+ interference. Values for [Mg2+]i are obtained by comparing the electrode potential measured in the cytosol minus membrane potential with the electrode potential of a calibration solution which, because of ion interferences, should be identical to the ionic composition of the cytosol.

[Mg2+]i in cell organelles and cytosol

[Mg2+]i in sarcoplasmic (endoplasmic) reticulum as measured by furaptra amounted to 1.0 mM [7].

[Mg2+]i in mitochondria is about the same as [Mg2+]i in the cytosol [8]. Values of 0.67 mM [9], 0.5 mM and 0.8 - 1.5 mM and 0.82 mM, determined by furaptra in isolated beef heart mitochondria, have been reported [10]. Since there is a membrane potential of 200 mV inside negative across the mitochondrial membrane, there should be an outside directed Mg2+ transport mechanism. Mg2+ influx into mitochondria may be mediated by a protein (Mrs2p) that is inserted into the inner mitochondrial membrane [11].

Tables 3 and 4( Table 4 ) present a selection of the values of [Mg2+]i in the cytosol taken from the enormous number of values reported by various investigators for different cell types and tissues. More values for [Mg2+]i measured by various methods are listed in [14, 68]. As shown in table 3, very different KDs for Mg furaptra and MgATP were used. The KDs varied by a factor of up to 4. However, the variation of [Mg2+]i within the same cell type is less expressed than was to be expected with respect to the different KDs e.g. in A7r5 cells, a rat embryonal aortic muscle derived cell line, or in brain.

When [Mg2+]i was measured in the same cell type (lymphocytes) by different methods (furaptra, null-point, Mg2+ electrode), different values (0.15 mM (table 4), 0.24 mM, 0.9 mM and 1.35 mM (table 3)) were obtained. In erythrocytes, the null- point method yielded higher values than 31P NMR (0.4 mM versus 0.2 mM). See also [8]. Also, the same method used by various investigators yielded very different values of [Mg2+]i in the same cell type: in resting platelets 0.266 mM to 0.644 mM, in VSMC 0.31 mM and 0.62 mM (table 4).

With Mg2+ microelectrodes, the first measurements of [Mg2+]i yielded rather high values [49, 50]. Later measurements yielded values for [Mg2+]i in the range as measured by other methods.
Table 4 Alteration of [Mg2+]i by various effectors measured by means of furaptra.

Cells

Effector

[Mg2+]i (mM)

Ref.

Resting

Stimulated

MDCK cells

8-Br-cGMP (0.1 mM)

0.552

0.682

[57]

MDCK cells

8-Br-cAMP (0.1 mM)

0.538

0.362

[57]

CTAL cells

ANP (1 μM)

0.525

0.592

[57]

CTAL cells

8-Br-cGMP (0.1 mM)

0.538

0.609

[57]

CTAL cells

PTH (1 μM)

0.540

0.497

[57]

CTAL cells

Calcitonin (1 μM)

0.542

0.462

[57]

Human platelets

Insulin (200 μU/ml)

0.266

0.355

[58]

Human platelets

Insulin (100 μU/ml)

0.614

1.270

[59]

Human platelets

Thrombin (0.1 U/ml)

0.614

0.405

[59]

Human platelets

Endothelin-1 (1nM)

0.58

0.59

[60]

Human platelets

Angiotensin-II (1 nM)

0.58

0.40

[60]

Human lymphocytes

PHA-L (5 mg/ml)

0.15

0.25

[61]

Fibroblasts

Insulin (100 ng/ml)

0.208

0.241

[62]

Fibroblasts

Bombesin (3 nM)

0.208

0.304

[62]

Fibroblasts

EGF (10 ng/ml)

0.208

0.244

[62]

Fibroblasts

Bombesin (3 nM)

0.328

0.538

[63]

Fibroblasts

Endothelin-1 (0.5 μM)

0.328

0.538

[63]

Sub.muc.acini

Carbachol (10 μM)

0.35

0.5

[64]

VSMC

AVP (1 μM)

0.31

2.44 (peak)

[65]

VSMC

AVP (1 μM)

0.31

0.42

[65]

VSMC

Endothelin-1 (1μM)

0.30

2.36 (peak)

[65]

VSMC

Endothelin-1 (1 μM)

0.30

0.43

[65]

VSMC

AVP (10 nM)

0.62

0.52

[66]

VSMC

Angiotensin-II (10nM)

0.62

0.8 (peak)

[66]

VSMC

Angiotensin-II (10 nM)

0.62

0.46

[66]

Panc.acinar cells

Acetylcholine (10 μM)

0.82

1.06 (peak)

[67]

Panc.acinar cells

Acetylcholine (10 μM)

0.82

0.61

[67]

Panc.acinar cells

Cholecystok. (10 nM)

0.82

1.01 (peak)

[67]

Panc.acinar cells

Cholecystok. (10 nM)

0.82

0.69

[67]

Panc.acinar cells

Cholecystok. (01 nM)

0.59

0.37

[55]

Uncertainty of [Mg2+]i measurements

Because of limited specificity in the measurement with Mg2+-sensitive electrodes, the calibration solution must be identical with the ionic composition of the cytosol. This can be done with respect to the cations. It is not possible for the cytosolic anions. Therefore, the calibration must be done on the basis of the activity of Mg2+ and not on the basis of the concentration of Mg2+. However, there is uncertainty about the activity coefficient of Mg2+. In an isotonic solution the activity coefficient may amount to 0.3 [69] or 0.55 [70]. The higher value is the more correct one. Besides an estimate of the activity coefficient according to Debye-Hückel for pure salt solutions, cytoplasma contains proteins that bind water (10%) without salt (non-solvent water). This effect and the interaction of Mg2+ with charges of macromolecules and membranes may lead to an additional reduction in the activity coefficient [71].

There is another common uncertainty. Also KDMg furaptra and KDMgATP must be determined in solutions identical to the ionic composition of the cytosol. However the solutions used are composed on the basis of chloride salts, and are thus different from the cytosolic anion composition. Due to its content of inorganic phosphate and phosphate esters, the Mg2+ activity coefficient in the cytosol is lower than in the chloride-containing solutions. Besides this uncertainty, the values for KDMg furaptra used by different investigators varied from 1.0-6.8 mM [5, 7, 10]. KD values estimated in situ yielded higher values (2.1 mM [9], 5.3 mM [27], 5.4 mM [27] and 6.8 mM [7]) than KDs determined under in vitro conditions (usually 1.5 mM).

For KDMgATP the situation is still more complex. 31P NMR measures the binding of Mg2+ to phosphoryl groups of ATP. Mg2+ binding is dependent on pH because the phosphate group dissociates at a pK value of about 6.8 [12], and is thus dependent on the intracellular pH. The degree by which the KD of MgATP is dependent on pH is shown in table 2B. Besides H+, other cations compete with Mg2+ for binding to ATP. This encludes a weak binding of K+ and Na+ to ATP (log KA = 0.99 and 0.98 M-1[12]). To prevent the interaction of K+ and Na+ with ATP, 0.1 M tetraethylammonium salt was taken to adjust ionic strength. The effect of the ionic strength on the dissociation constant of MgATP is shown in table 2C.

A more realistic determination of KD of MgATP was performed using an Mg2+-sensitive electrode and a background solution containing 140 mM K+ and 14.6 mM Na+. A value of 87.4 μM was obtained at pH 7.2 and 37° C [14, 20]. The same value (86 μM) was obtained by means of 31P NMR under approximately in vivo conditions [39].

When the more realistic KD of MgATP was used to recalculate the values of [Mg2+]i measured by other investigators, the values for [Mg2+]i increased to a factor of 2.8 [14]. Values of 0.7 to 1.7 mM were obtained for 14 determinations of [Mg2+]i in various tissues [14].

Microheterogeneity of [Mg2+]i in the cytosol

The above reported values of [Mg2+]i are average values over total cytosol. Compartmentation of cytosolic Mg2+ was not considered. However, Mg2+ is not uniformly distributed within the cytosol. Mg2+ is enriched at negatively charged phospholipids of cellular and intracellular membranes and at the surface of negatively charged macromolecules. For a detailed discussion see [2]. The differently enriched Mg2+ relates to free Mg2+. There is experimental evidence for a different distribution of free Mg2+ within the cytosol.

Furaptra applied in cultured rat aortic smooth muscle cells and using a KD of 1.5 mM yielded an [Mg2+]i of 0.2 mM in the peripheral area, 0.6 mM in the perinuclear region and about 0.6 mM in the nuclear region [72]. A heterogeneous distribution of intracellular free Mg2+ in rat VSMC was also found by other investigators [73] using furaptra. Using a KD of 1.45 mM, [Mg2+]i in the nuclear region was 0.32 mM. [Mg2+]i in the perinuclear region, which contains the highest density of intracellular organelles, amounted to 0.4-1.13 mM and the non- nuclear cytoplasmic area had an [Mg2+]i of 0.77 mM. The peripheral region near the plasma membrane had the lowest [Mg2+]i. By using mag-indo-1, other authors [74] found a mean [Mg2+]i of 1.4 mM in human tracheal gland cells. Within a single cell, [Mg2+]i was uniformly distributed within the nucleoplasm. Cytosolic [Mg2+]i varied from 0.34 mM to 3 mM in another opposing region in the same cell.

Since positively charged Mg2+ ions are enriched at negatively charged membranes and macromolecules, it must be expected that the negatively charged furaptra is rejected by these structures, resulting in erroneous values of [Mg2+]i. This may be a reason why a low [Mg2+]i was measured with furaptra near the plasma membrane, although Mg2+ should be enriched at the inner side of the negatively charged plasma membrane.

Taken together, besides the uncertainty in the average values of [Mg2+]i in the cytosol, there is an unequal distribution of free Mg2+ in the cytosol by a factor ranging between 3 and 10. The high [Mg2+]i cannot be explained by enrichment of free Mg2+ in cell organelles (e.g. mitochondria, endoplasmic reticulum) because [Mg2+]i in these cell organelles was about the same as the average [Mg2+]i in the cytosol (see above). The mechanism causing the heterogeneous distribution of intracellular free Mg2+ is not defined.

Metabolic function of intracellular Mg2+

In view of these facts, it is uncertain to define an absolute and exact value of [Mg2+]i within a defined space of the cytosol. Besides compartmentation of free Mg2+ in the cytosol, cytosolic metabolic pathways such as glycogenolysis and glycolysis are also compartmentalized [75, 76].

Since Mg2+ is enriched at negatively charged membranes, an exact knowledge of [Mg2+]i at the inner surface of cell membranes would be essential to define the role of intracellular Mg2+ in the regulation of membrane-bound metabolic pathways and in the modulation of K+ and Ca2+ channels [77] as well as the role of intracellular Mg2+ in the feedback inhibition of Mg2+ influx via TRPM7 in the regulation of [Mg2+]i[78, 79].

Generally, metabolic pathways are regulated by changing the activity of the rate-limiting enzymes. Usually these are allosteric enzymes with a complex regulation by activation and feedback inhibition by various metabolites, end products of biosynthesis and by effectors. Moreover, these enzymes can be regulated by phosphorylation-dephosphorylation. During evolution, the regulation of metabolic pathways was adapted to the requirements of the cell with respect to energy supply as well as intermediates and end products for biosynthesis.

What is the role of intracellular Mg2+ in these mechanisms? All reactions of Mg2+ with ligands such as low molecular substances (ATP, etc.), proteins, enzymes, and nucleic acids obey the law of mass action, yielding a sigmoidal curve when plotted as a function of pMg. With respect to Mg2+-dependent enzymes at high [Mg2+]i, enzymes are usually inhibited by Mg2+. Activation and inhibition of an enzyme by Mg2+ as a function of pMg results in a bell-shaped curve [1]. Activation by Mg2+ occurs at the ascending part of the bell-shaped curve up to the pMg optimum. Alterations of [Mg2+]i near or within the range of the pMg optimum of a Mg2+-dependent rate-limiting enzyme have no significant effect on the rate of a metabolic pathway.

Since the exact absolute value of [Mg2+]i in the cytosol is uncertain (see above) and as there are considerable differences in the values of [Mg2+]i for the same cell type (tables 3, 4), it is uncertain at which degree of activation (part of the bell-shaped pMg dependency) the Mg2+-dependent rate-limiting enzymes are operating.

For some glycolytic enzymes, the pMg optimum is at pMg 3 [80, 81]. However, the Mg2+ affinity and the pMg optimum of enzymes can change. This effect was shown for isolated glycolytic enzymes, when their Mg2+ dependency was determined at various constant Mg2+: ATP or Mg2+ : ADP ratios [81]. This effect may occur in intact cells. The synthesis of ATP and the utilization of ATP in the cytosol is compartmentalized [75, 76]. In organisms, there is an additional mechanism that can change the affinity of Mg2+ to enzymes. For example, the addition of glucagon to liver cells resulted in a dramatic decrease in the KM of adenylyl cyclase for Mg2+[82].

In all Mg2+-dependent enzymes, which use MgATP as a substrate, an alteration of [Mg2+]i has only a minor effect on the enzyme activity because ATP is nearly saturated with Mg2+ (to about 90%). Moreover, an alteration of MgATP affects enzyme activity according to Michaelis-Menten kinetics and depends on the KM of MgATP and the MgATP concentration. Intracellular Mg2+ is buffered at a high level [20, 83]. Thus, intracellular Mg2+ is not suitable for a regulatory function. Its metabolic function can be tested by artificially changed [Mg2+]i in experiments with intact cells. In such experiments it was found that [Mg2+]i did not play a regulatory role in erythrocyte glycolysis [84].

When cells [85] or isolated mitochondria [86] were drastically Mg2+-depleted by means of A23187, respiration was reduced. In these experiments, [Mg2+]i in mitochondria was not measured. Because of the complex effects under the experimental conditions, it cannot be decided whether [Mg2+]i in mitochondria has a regulatory or a permissive function. [Ca2+]i in mitochondria was also changed in these experiments and may have affected respiration. For a discussion of the interaction of H+, Ca2+, inorganic phosphate, spermine and various cofactors with Mg2+ in respiration and oxidative phosphorylation, see [87].

The synthesis of purine and pyrimidine precursors of nucleic acids depends on Mg2+, and at each step of DNA replication, RNA transcription and RNA translation Mg2+ is required for enzyme function. Mg2+ is a cofactor in all these processes. Regulation of enzyme activity through changes in [Mg2+]i has not been observed [88].

Computer models have shown that Mg2+ does not regulate cardiac metabolism [89].

A drastic reduction in the cellular Mg2+ content by means of A23187 yielded a reduction in the biosynthesis of proteins, DNA and RNA, respiration and glycolysis [85]. Again these experiments did not prove that intracellular Mg2+ has a regulatory function. They may indicate a permissive function of intracellular Mg2+. Alternatively to conclusions about a permissive role of intracellular free Mg2+, other authors have suggested a regulatory function of intracellular free Mg2+[89-92].

Mg2+ content in malignant cells

Rapidly dividing normal cells have higher contents of Mg2+, K+, Na+ and Cl- than slowly growing normal cells [93]. In rapidly dividing tumor cells, the concentrations of intracellular Na+ and Cl- were elevated, whereas intracellular total Mg2+ and K+ contents were significantly lower than in rapidly dividing normal cells. Injection of tumorous mice with amiloride reduced [Na+]i and cell proliferation without significantly changing total Mg2+ and K+ content. It was concluded that an early brief surge in [Ca2+]i is essential in mitogenic stimulation followed by an increase in [Na+]i and pHi[93].

When rapidly dividing HL60 cells, a promyelocytic leukemia cell line, were transformed to neutrophilic-like cells by incubation with retinoic acid, the total Mg2+ content of the cells was reduced by 19%. The total Mg2+ content in mitochondria and cytoplasm (cytoplasm was defined as the region excluding mitochondria and nuclei) were reduced by 18%, and the Mg2+ content of nuclei was unchanged [94]. The reduction of total Mg2+ content in cytoplasm may be caused by a reduction of ATP by 31% and ADP by 40% [94], and by an increase in Na+/Mg2+ antiport [95]. An alteration of Mg2+ bound to ribosomes was not investigated. Total cytoplasmic Ca2+ content in the transformed cells was reduced by 40%, and the K+/Na+ ratio in nuclei was reduced by about 28% [94]. The complex mechanisms by which the contents of the various ions were changed during the differentiation process of the cells and their metabolic significance are not defined.

Action of effectors on [Mg2+]i and [Ca2+]i

[Mg2+]i in nucleated cells is somewhat constant. It can be changed significantly by effectors. The development of furaptra and fura-2 offered the possibility of rapidly and continuously measuring [Mg2+]i and [Ca2+]i and their alterations by various effectors.

When intracellular Mg2+ has a regulatory function, [Mg2+]i must be changed by effectors at a reasonable concentration within a reasonable time period and to a reasonable extent. The alterations of [Mg2+]i after addition of various effectors are listed in table 4. Remarkably, different investigators measured different values of [Mg2+]i in resting platelets and a different increase of [Mg2+]i by insulin as well as controversial effects by thrombin in these cells. Thrombin decreased [Mg2+]i in human platelets from 0.614 mM to 0.405 mM [59], whereas other authors found an increase in [Mg2+]i in platelets from 0.54 mM to 1.33 mM by thrombin [96].

The increases in [Mg2+]i induced by various effectors at the concentrations listed amounted maximally to a factor of 2, corresponding to an alteration in pMg of 0.3. A small part of the increase in [Mg2+]i by some effectors may include an increase in [Ca2+]i because of the unspecificity of furaptra. Due to the uncertainty of an absolute value of [Mg2+]i, the alterations in [Mg2+]i must be considered as relative.

Of the effectors listed in table 4, insulin had no effect on [Ca2+]i[58, 59]. Insulin may increase Mg2+ uptake into platelets. In VSMC, vasopressin [65, 66] and endothelin-1 [65] induced rapid peaks of [Mg2+]i and [Ca2+]i followed by a decrease in [Mg2+]i and [Ca2+]i. The peak and sustained values of [Mg2+]i are listed in table 4. The reduction in [Mg2+]i may be caused by Mg2+ efflux via Na+/Mg2+ antiport [65]. Mg2+- and Ca2+-free medium decreased the vasopressin-mobilized [Ca2+]i by 60.8% and prevented the increase in [Mg2+]i[65]. Based on these results, the authors concluded that vasopressin and endothelin-1 mobilized Mg2+ in VSMC through the action of the intracellular second messenger Ca2+. However, in A7r5 cells, a VSMC line, 100 nM vasopressin had no effect on [Mg2+]i[26].

In fibroblasts, bombesin induced an [Mg2+]i and [Ca2+]i peak [62, 63], followed by a sustained decrease in [Mg2+]i and by oscillations of [Ca2+]i. Endothelin-1 (0.5μM) had a similar effect on [Mg2+]i as 3 nM bombesin. There was a considerable variation in the [Mg2+]i response to bombesin, endothelin-1 [63] and EGF [97] among different individual cells of the same cell type.

Some effectors have a cell -specific action, e.g. endothelin-1 had no effect on [Mg2+]i and [Ca2+]i in platelets [60]. 8-Br-cGMP increased [Mg2+]i in MDCK cells [57] and had no effect on [Mg2+]i in platelets [59].

The increase in [Mg2+]i by AVP and endothelin-1 [65] affected [Ca2+]i and [Mg2+]i simultaneously and in the same direction. In VSMC, AVP and endothelin [65] and in pancreatic acinar cells, acetylcholine and cholecystokinin induced short peaks of [Mg2+]i followed by a decrease in [Mg2+]i[67]. In a more detailed study with pancreatic acinar cells, 100 pM cholecystokinin and 100 μM acetylcholine decreased [Mg2+]i from 0.58 mM to 0.47 mM. This may be caused by Mg2+ uptake into the endoplasmic reticulum [55] or by Mg2+ efflux via Na+/Mg2+ antiport [65, 67]. Cholecystokinin (10 pM) induced [Ca2+]i oscillations. Frequency and amplitude of [Ca2+]i oscillations were increased when [Mg2+]i was decreased by preincubation at low extracellular Mg2+ concentration [55]. Thus, intracellular Mg2+ can modulate Ca2+ signaling.

The reviewed alterations in [Ca2+]i reflect the general function of Ca2+ as a second messenger. Ca2+ signaling can occur as a single transition, as a sustained plateau or as repetitive oscillations. [Ca2+]i oscillations are known to be involved in the control of a number of important cell processes, e.g. regulation of gene transcription, where the efficacy of the control varies with the amplitude and frequency of the oscillations [98, 99]. The different patterns of intracellular Ca2+ reveal a mechanism by which a multifunctional second messenger as Ca2+ can achieve specificity in signal transduction [98, 99].

Ca2+ versus Mg2+ as a second messenger

From the results it can be concluded that some effectors (vasopressin, endothelin-1, bombesin, cholecystokinin, acetylcholine, carbachol) primarily increase [Ca2+]i which secondarily increase [Mg2+]i through liberation of intracellular Mg2+. The mechanism of Mg2+ liberation is not defined. From other experiments it has been suggested that bound Mg2+ may be released through acidification and by displacement of protein-bound Mg2+ by Ca2+[100, 101]. In experiments with pancreatic acinar cells, an alteration of pHi had no effect on cholecystokinin-induced changes of [Mg2+]i. The changes in [Mg2+]i were related to the release and reuptake of Mg2+ by the endoplasmatic reticulum [55]. Competition of Ca2+ with protein-bound Mg2+ may be the probable mechanism. The function of the effector-induced increase in [Mg2+]i may enhance Mg2+-dependent reactions to support the effector-induced mechanisms in the target cells.

The effector-induced alterations of [Mg2+]i were discussed as evidence that intracellular Mg2+ is a second messenger [94]. It merely indicates that intracellular Mg2+ can affect the action of Ca2+ as a second messenger. Additional evidence that intracellular Ca2+ but not Mg2+ is the second messenger was obtained with human lymphocytes stimulated by Con A. Con A increased [Ca 2+]i and [Mg2+]i. However, [Mg2+]i was only elevated in cells with a high [Ca2+]i[102]. This result indicates that a sufficient increase in [Ca2+]i is necessary to induce the increase in [Mg2+]i.

In the complex interactions between intracellular Mg2+ and Ca2+, [Mg2+]i has a level at which Ca2+ release is almost maximally inhibited, and Ca2+ storage is almost maximally activated by intracellular Mg2+. Thus [Mg2+]i provides a minimal [Ca2+]i, so that effectors can induce pronounced changes in [Ca2+]i[103].

These results are in agreement with the physico-chemical properties of Ca2+.

Because of the larger diameter of Ca2+ compared with Mg2+, in multidentate chelates with proteins there is less ligand-ligand repulsion by the negatively charged chelating groups. This yields 1000 times lower dissociation constants of Ca2+ with Ca2+-binding proteins compared with Mg2+ and to 1000 times lower [Ca2+]i compared with [Mg2+]i. Thus Ca2+ was favored against Mg2+ as a second messenger during evolution. For details see [99, 104].

Conclusion

Intracellular Mg2+ is buffered by reversibly binding to ligands such as nucleotides, nucleic acids, proteins, phospholipids and negatively charged low molecular substances. The exact average value of [Mg2+]i is uncertain due to methodical difficulties and higher than usually reported. Intracellular free Mg2+ and metabolic pathways are compartmentalized. The Mg2+ affinity and pMg optimum of enzymes can be changed by altering pH, [Ca2+]i, substrates, end products, effectors and hormones. Therefore, the exact quantitative role of intracellular Mg2+ under the conditions of an intact cell or tissue cannot be defined. The increase in [Mg2+]i in various cell types by effectors is small. Various effectors increase [Ca2+]i and [Mg2+]i. The alterations in [Ca2+]i are more expressed than the alterations in [Mg2+]i. The evidences favor intracellular Ca2+ as a second messenger. The simultaneous increase in [Mg2+]i may activate Mg2+-dependent reactions to support effector-induced mechanisms in target cells [19].

References

1 Ebel H, Günther T. Magnesium metabolism: A. review. J Clin Chem Clin Biochem 1980; 18: 257-70.

2 Günther T. Functional compartmentation of intracellular magnesium. In: Sigel H, Sigel A, eds. Metal ions in biological systems, Vol. 26. New York, Basel: Marcel Dekker Inc, 1990: 193-213.

3 Mota De Freitas D, Dorus E. Techniques for measuring magnesium in tissues from hypertensive, psychiatric, and neurological patients. In: Birch NJ, ed. Magnesium and the cell. London, Boston, San Diego, New York, Sydney, Tokyo: Academic Press, 1993: 51-79.

4 London RE. Methods for measurement of intracellular magnesium: NMR and fluorescence. Annu Rev Physiol 1991; 53: 241-58.

5 Murphy E. Measurement of intracellular ionized magnesium. Miner Electrolyte Metab 1993; 19: 250-8.

6 Konstanczak P, Schäfer A, Sperner J, Günther T. Calculation of free Mg2+ concentration from 31P-NMR spectra of ATP. Magnes Bull 2000; 22: 20-5.

7 Sugiyama T, Goldman WF. Measurement of SR free Ca2+ and Mg2+ in permeabilized smooth muscle cells with use of furaptra. Am J Physiol 1995; 269: C698-C705.

8 Günther T. Die intrazelluläre Mg-Ionenkonzentration. Z Naturforsch 1967; 22b: 149-54.

9 Jung DW, Brierley GP. Matrix free Mg2+ and the regulation of mitochondrial volume. Am J Physiol 1999; 277: C1194-C1201.

10 Jung DW, Brierley GP. Determination of free Mg2+ in isolated heart mitochondria using fluorescent probes. Magnes Trace Elem 1991-1992; 10: 151-64.

11 Weghuber J, Dieterich F, Froschauer EM, Svidovà S, Schweyen RJ. Mutational analysis of functional domains in Mrs2p, the mitochondrial Mg2+ channel protein of Saccharomyces cerevisiae. FEBS J 2006; 273: 1198-209.

12 Sillen LG, Martell AE. Stability constants of metal-ion complexes. London: The Chemical Society Burlington House, 1971.

13 Nanninga LB. The association constant of the complexes of adenosine triphosphate with magnesium, calcium, strontium and barium ions. Biochim Biophys Acta 1961; 54: 330-8.

14 Zhang W, Truttmann AC, Lüthi D, McGuigan JAS. Apparent Mg2+-adenosine 5- triphosphate dissociation constant measured with Mg2+ macroelectrodes under conditions pertinent to 31P NMR ionized magnesium determinations. Anal Biochem 1997; 251: 246-50.

15 Gupta RK, Gupta P, Yushok WD, Rose ZB. Measurement of the dissociation constant of MgATP at physiological nucleotide levels by a combination of 31P NMR and optical absorbance spectroscopy. Biochem Biophys Res Commun 1983; 117: 210-5.

16 Berger H, Jänig GR, Gerber G, Ruckpaul H, Rappoport SM. Interaction of haemoglobin with ions. Interactions among magnesium, adenosine 5’-triphosphate, 2,3 bisphosphoglycerate, and oxygenated and deoxygenated human haemoglobin under simulated intracellular conditions. Eur J Biochem 1973; 38: 553-62.

17 Gupta RK, Benovic JL, Rose ZB. The determination of the free magnesium level in the human red blood cell by 31P NMR. J Biol Chem 1978; 253: 6172-6.

18 Woods KL, Walmsley D, Heagerty AM, Turner DL, Lian L-Y. 31P nuclear magnetic resonance measurement of free erythrocyte magnesium concentration in man and its relation to blood pressure. Clin Sci 1988; 74: 513-7.

19 Williams GD, Mosher TJ, Smith MB. Simultaneous determination of intra-cellular magnesium and pH from the three 31P NMR chemical shifts of ATP. Anal Biochem 1993; 214: 458-67.

20 Lüthi D, Günzel D, McGuigan JAS. Mg-ATP binding: Its modification by spermine, the relevance to cytosolic Mg2+ buffering, changes in the intra-cellular ionized Mg2+ concentration and the estimation of Mg2+ by 31P-NMR. Exp Physiol 1999; 84: 231-52.

21 Westerblad H, Allen DG. Myoplasmic Mg2+ concentration in Xenopus muscle fibres at rest, during fatigue and during metabolic blockade. Exper Pysiol 1992; 77: 733-40.

22 Murphy E, Freudenrich CC, Levy LA, London RE, Lieberman M. Monitoring cytosolic free magnesium in cultured chicken heart cells by use of the fluorescent indicator furaptra. Proc Natl Acad Sci USA 1989; 86: 2981-4.

23 Raju B, Murphy E, Levy LA, Hall RD, London RE. A fluorescent indicator for measuring cytosolic free magnesium. J Am Physiol 1989; 256: C540-C548.

24 Altura BM, Zhang A, Cheng TPO, Altura BT. Cocaine induces rapid loss of intracellular free Mg2+ in cerebral vascular smooth muscle cells. Eur J Pharmacol 1993; 246: 299-301.

25 Tashiro M, Konishi M. Basal intracellular free Mg2+ concentration in smooth muscle cells of guinea pig tenia cecum: intracellular calibration of the fluorescent indicator furaptra. Biophys J 1997; 73: 3358-70.

26 Schachter M, Gallagher KL, Sever PS. Measurement of intracellular magnesium in a vascular smooth muscle cell line using a fluorescent probe. Biochim Biophys Acta 1990; 1035: 378-80.

27 Watanabe M, Konishi M. Intracellular calibration of the fluorescent Mg2+ indicator furaptra in rat ventricular myocytes. Pflügers Arch Eur J Physiol 2001; 442: 35-40.

28 Grubbs RD, Walter A. Determination of cytosolic Mg2+ activity and buffering in BC3H-1 cells with mag-fura-2. Mol Cell Biochem 1994; 136: 11-22.

29 Lennard R, Singh J. Secretagogue-evoked changes in intracellular free magnesium concentrations in rat pancreatic acinar cells. J Physiol 1991; 435: 483-92.

30 Delva P, Pastori C, Degan M, Montesi G, Lechi A. Catecholamine-induced regulation in vitro and ex vivo of intralymphocyte ionized magnesium. J Membr Biol 2004; 199: 163-71.

31 Csernoch L, Bernengo JC, Szentesi P, Jacquemond V. Measurements of intracellular Mg2+ concentration in mouse skeletal muscle fibers with the fluorescent indicator mag-indo-1. Biophys J 1998; 75: 957-67.

32 Resnick LM, Altura BT, Gupta RK, Laragh JH, Alderman MH, Altura BM. Intracellular and extracellular magnesium depletion in type 2 (non-insulin- dependent) diavetes mellitus. Diabetologia 1993; 36: 767-70.

33 Petersen A, Kristensen SR, Jacobsen JP, Horder M. 31P-NMR measurements of ATP, ADP, 2,3-diphosphoglycerate and Mg2+ in human erythrocytes. Biochim Biophys Acta 1990; 1035: 169-74.

34 Flatman PW. The effect of buffer composition and deoxygenation on the concentration of ionized magnesium inside human red blood cells. J Physiol 1980; 300: 19-30.

35 Günther T, Vormann J, Höllriegl V. Concentration of intracellular free Mg2+ and Mg2+ efflux from magnesium-deficient erythrocytes. Magnes Bull 1990; 12: 43-6.

36 Golding EM, Dobson GP, Golding RM. A critical assessment of noise-induced errors in 31P MRS: application to the measurement of free intracellular magnesium in vivo. MRM 1996; 35: 174-85.

37 Brooks KJ, Bachelard HS. Changes in intracellular free magnesium during hypoglycaemia and hypoxia in cerebral tissue as calculated from 31P-nuclear magnetic resonance spectra. J Neurochem 1989; 53: 331-4.

38 Halvorson HR, Van de Linde AMQ, Helpern JA, Welch KMA. Assessment of magnesium concentrations by 31P NMR in vivo. NMR Biomed 1992; 5: 53-8.

39 Malloy CR, Cunningham CC, Radda GK. The metabolic state of the rat liver in vivo measured by 31P-NMR spectroscopy. Biochim Biophys Acta 1986; 885: 1-11.

40 Desmoulin F, Cozzone PJ, Canioni P. Phosphorus-31 nuclear-magnetic- resonance study of phosphorylated metabolites compartmentation, intracellular pH and phosphorylation state during normoxia. hypoxia and ethanol perfusion, in the perfused rat liver. Eur J Biochem 1987; 162: 151-9.

41 Kushmerick MJ, Dillon PF, Meyer RA, Brown TR, Krisanda JM, Sweeney HL. 31P NMR spectroscopy, chemical analysis, and free Mg2+ of rabbit bladder and uterine smooth muscle. J Biol Chem 1986; 261: 14420-9.

42 Ryschon TW, Rosenstein DL, Rubinow DR, Niemela JE, Elin RJ, Balaban RS. Relationship between skeletal muscle intracellular ionized magnesium and measurements of blood magnesium. J Lab Clin Med 1996; 127: 207-13.

43 Wu ST, Pieper GM, Salhany JM, Eliot RS. Measurement of free magnesium in perfused and ischemic arrested heart muscle. A quantitative phosphorus-31 nuclear magnetic resonance and multiequilibria analysis. Biochemistry 1981; 20: 7399-403.

44 Gupta RK, Moore RD. 31P NMR studies of intracellular free Mg2+ in intact frog skeletal muscle. J Biol Chem 1980; 255: 3987-93.

45 Nakayama S, Nomura H, Tomita T. Intracellular free magnesium in the smooth muscle of guinea pig taenia caeci: a concomitant analysis for magnesium and pH upon sodium removal. J Gen Physiol 1994; 103: 833-51.

46 Gupta RK, Yushok WD. Noninvasive 31P NMR probes of free Mg2+. MgATP, and MgADP in intact Ehrlich ascites tumor cells. Proc Natl Acad Sci USA 1980; 77: 2487-91.

47 Ware JA, Smith M, Fossel ET, Salzman EW. Cytoplasmic Mg2+ concentration in platelets: implications for determination of Ca2+ with aequorin. Am J Physiol 1988; 255: H855-H859.

48 Rink TJ, Tsien RY, Pozzan T. Cytoplasmic pH and free Mg2+ in lymphocytes. J Cell Biol 1982; 95: 189-96.

49 Lopez JR, Alamo L, Caputo C, Vergara J, DiPolo R. Direct measurement of intracellular free magnesium in frog skeletal muscle using magnesium-selective microelectrodes. Biochim Biophys Acta 1984; 804: 1-7.

50 Hess P, Metzger P, Weingart R. Free magnesium in sheep, ferret and frog striated muscle at rest measured with ion-selective micro-electrodes. J Physiol 1982; 333: 173-88.

51 Günzel D, Galler S. Intracellular free Mg2+ concentration in skeletal muscle fibres of frog and crayfish. Pflügers Arch Eur J Physiol 1991; 417: 446-53.

52 MacDermott M. The intracellular concentration of free magnesium in extensor digitorum longus muscles of the rat. Exp Physiol 1990; 75: 763-9.

53 Buri A, Chen S, Fry CH, Illner H, Kickenweiz E, McGuigan JAS, Noble D, Powell T, Twist VW. The regulation of intracellular Mg2+ in guinea-pig heart, studied with Mg2+-selective microelectrodes and fluorochromes. Exp Physiol 1993; 78: 221-33.

54 Buri A, McGuigan JAS. Intracellular free magnesium and its regulation, studied in isolated ferret ventricular muscle with ion-selective microelectrodes. Exp Physiol 1990; 75: 751-61.

55 Mooren FC, Turi S, Günzel D, Schlue W-R, Domschke W, Singh J, Lerch MM. Calcium-magnesium interactions in pancreatic acinar cells. FASEB J 2001; 15: 659-72.

56 Alvarez-Leefmans FJ, Gamino SM, Rink TJ. Intracellular free magnesium in neurones of Helix Aspersa measured with ion-selective micro-electrodes. J Physiol 1984; 354: 303-17.

57 Dai L-J, Quamme GA. Cyclic nucleotides alter intracellular free Mg2+ in renal epithelial cells. Am J Physiol 1992; 262: F1100-F1104.

58 Hwang DL, Yen CF, Nadler JL. Insulin increases intracellular magnesium transport in human platelets. J Clin Endocrinol Metab 1993; 76: 549-53.

59 Takaya J, Higashino H, Miyazaki R, Kobayashi Y. Effects of insulin and insulin- like growth factor-1 on intracellular magnesium of platelets. Exp Mol Pathol 1998; 65: 104-9.

60 Touyz RM, Schiffrin EL. The effect of angiotensin II on platelet intracellular free magnesium and calcium ionic concentrations in essential hypertension. J Hypertens 1993; 11: 551-8.

61 Ng LL, Davies JE, Garrido MC. Intracellular free magnesium in human lymphocytes and the response to lectins. Clin Sci 1991; 80: 539-47.

62 Ishijima S, Sonoda T, Tatibana M. Mitogen-induced early increase in cytosolic free Mg2+ concentration in single Swiss 3T3 fibroblasts. Am J Physiol 1991; 261: C1074-C1080.

63 Ishijima S, Tatibana M. Rapid mobilization of intracellular Mg2+ by bombesin in Swiss 3T3 cells: Mobilization through external Ca2+- and tyrosine kinase- dependent mechanisms. J Biochem (Tokyo) 1994; 115: 730-7.

64 Zhang GH, Melvin JE. Secretagogue-induced mobilization of an intracellular Mg2+ pool in rat sublingual mucous acini. J Biol Chem 1992; 267: 20721-7.

65 Okada K, Ishikawa S-E, Saito T. Cellular mechanisms of vasopressin and endothelin to mobilize [Mg2+]i in vascular smooth muscle cells. Am J Physiol 1992; 263: C873-C878.

66 Touyz RM, Schiffrin EL. Angiotensin II and vasopressin modulate intracellular free magnesium in vascular smooth muscle cells through Na+-dependent protein kinase C pathways. J Biol Chem 1996; 271: 24353-8.

67 Singh J, Wisdom DM. Second messenger role of magnesium in pancreatic acinar cells of the rat. Mol Cell Biochem 1995; 149/150: 175-82.

68 Rotevatn S, Sarheim H, Murphy E. Intracellular free magnesium concentration: relevance to cardiovascular medicine. Acta Physiol Scan 1991; S599: 125-33.

69 Drakenberg T. Physical methods for studying the biological chemistry of magnesium. In: Cowan JA, ed. The Biological Chemistry of Magnesium. New York, Weinheim, Cambridge: VCH Publishers Inc., 1995: 27.

70 Stauff J, Jaenicke R. Physikalische Chemie der Lösungen. In: Rauen HM, ed. Biochemisches Taschenbuch,2. Teil, 2. Auflage. Berlin, Göttingen, Heidelberg, New York: Springer-Verlag, 1964: S.37.

71 Reboiras MD, Pfister H, Pauly H. Activity coefficients of salts in highly concentrated protein solutions. I. Alkali chlorides in isoionic bovine serum albumin solutions. Biophys Chem 1978; 9: 37-46.

72 Altura BM, Altura BT. Role of magnesium in the pathogenesis of hypertension updated: Relationship to its actions on cardiac, vascular smooth muscle, and endothelial cells. In: Laragh JH, Brenner BM, eds. Hypertension: Pathophysiology, Diagnosis and Management, sec ed. New York: Raven Press, Ltd, 1995: 1213-42.

73 Quamme GA, Dai L-J, Rabkin SW. Dynamics of intracellular free Mg2+ changes in a vascular smooth muscle cell line. Am J Physiol 1993; 265: H281-H288.

74 Sébille S, Millot JM, Maizières M, Arnaud M, Delabroise AM, Jacquot J, Manfait M. Spatial and temporal Mg2+ signaling in single human tracheal gland cells. Biochem Biophys Res Commun 1996; 227: 743-9.

75 Han JW, Thieleczek R, Varsanyi M, Heilmeyer Jr. LMG. Compartmentalized ATP synthesis in skeletal muscle triads. Biochemistry 1992; 31: 377-84.

76 Xu KY, Zweier JL, Becker LC. Functional coupling between glycolysis and sarcoplasmic reticulum Ca2+ transport. Circ Res 1995; 77: 88-97.

77 Agus ZS, Morad M. Modulation of cardiac ion channels by magnesium. Annu Rev Physiol 1991; 53: 299-307.

78 Gwanyanya A, Amuzescu B, Zakharov SI, Macianskiene R, Sipido KR, Bolotina VM, Vereecke J, Mubagwa K. Magnesium-inhibited, TRPM6/7-like channel in cardiac myocytes: permeation of divalent cations and pH-mediated regulation. J Physiol 2004; 559: 761-76.

79 Fleig A, Penner R. The TRPM ion channel subfamily: molecular, biophysical and functional features. Trends Pharmacol Sci 2004; 25: 633-9.

80 Günther T. Beiträge zur biologischen Bedeutung des Magnesiums. Habilitationsschrift FU Berlin, 1965.

81 Garner PS, Rosett T. The influence of Mg2+/adenine nucleotide ratios and absolute concentration of Mg2+/adenine nucleotide on the observed velocity of some kinase reactions. FEBS Lett 1973; 34: 243-6.

82 Iyengar R, Birnbaumer L. Hormone receptor modulates the regulatory component of adenylyl cyclase by reducing its requirement for Mg2+ and enhancing its extent of activation by guanine nucleotides. Proc Natl Acad Sci USA 1982; 79: 5179-83.

83 Günther T. Über die Rolle des Mg bei der Regulation des Zellstoffwechsels. Z Naturforsch 1966; 21b: 1174-7.

84 Laughlin MR, Thompson D. The regulatory role for magnesium in glycolytic flux of the human erythrocyte. J Biol Chem 1996; 271: 28977-83.

85 Günther T, Vormann J, Förster R. Functional compartmentation of intracellular magnesium. Magnes Bull 1984; 6: 77-81.

86 Panov A, Scarpa A. Mg2+ control of respiration in isolated rat liver mitochondria. Biochemistry 1996; 35: 12849-56.

87 Rodriguez-Zavala JS, Moreno-Sanchez R. Modulation of oxidative phosphorylation by Mg2+ in rat heart mitochondria. J Biol Chem 1998; 273: 7850-5.

88 Vernon WB. The role of magnesium in nucleic-acid and protein metabolism. Magnesium 1988; 7: 234-48.

89 Garfinkel D, Garfinkel L. Magnesium and regulation of carbohydrate metabolism at the molecular level. Magnesium 1988; 7: 249-61.

90 Grubbs RD, Maguire ME. Magnesium as a regulatory cation: criteria and evaluation. Magnesium 1987; 6: 113-27.

91 Takaya J, Higashino H, Kobayashi Y. Can magnesium act as a second messenger? Current data on translocation induced by various biologically active substances. Magnes Res 2000; 13: 139-46.

92 Rubin H. The membrane, magnesium, mitosis (MMM) model of cell proliferation control. Magnes Res 2005; 18: 268-74.

93 Cameron IL, Smith NKR. Cellular concentration of magnesium and other ions in relation to protein synthesis, cell proliferation and cancer. Magnesium 1989; 8: 31-44.

94 Di Francesco A, Desnoyer RW, Covacci V, Wolf FI, Romani A, Cittadini A, Bond M. Changes in magnesium content and subcellular distribution during retinoic acid-induced differentiation of HL 60 cells. Arch Biochem Biophys 1998; 360: 149-57.

95 Wolf FI, Covacci V, Bruzzese N, Di Francesco A, Sacchetti A, Corda D, Cittadini A. Differentiation of HL-60 promyelocytic leukemia cells is accompanied by a modification of magnesium homeostasis. J Cell Biochem 1998; 71: 441-8.

96 Matsuno K, Koyama M, Takeda H, Abe K, Sakurada K, Miyazaki T, Kobayashi K. Cytosolic free magnesium concentration in human platelets. Thromb Res 1993; 69: 131-7.

97 Grubbs RD. Effect of epidermal growth factor on magnesium homeostasis in BC3H1 myocytes. Am J Physiol 1991; 260: C1158-C1164.

98 Dolmetsch RE, Lewis RS, Goodnow CC, Healy JI. Differential activation of transcription factors induced by Ca2+ response amplitude and duration. Nature 1997; 386: 855-8.

99 Carafoli E. Calcium - a universal carrier of biological signals. FEBS J 2005; 272: 1073-89.

100 Freudenrich CC, Murphy E, Liu S, Lieberman M. Magnesium homeostasis in cardiac cells. Mol Cell Biochem 1992; 114: 97-103.

101 Murphy E. Mysteries of magnesium homeostasis. Circ Res 2000; 86: 245-8.

102 Rijkers GT, Griffioen AW. Changes in free cytoplasmic magnesium following activation of human lymphocytes. Biochem J 1993; 289: 373-7.

103 Günther T, Vormann J. Intracellular Ca2+-Mg2+ interactions. Ren Physiol 1994; 17: 279-86.

104 Günther T. Phylogenesis and ontogenesis of magnesium. Magnes Bull 1994; 16: 143-6.


 

About us - Contact us - Conditions of use - Secure payment
Latest news - Conferences
Copyright © 2007 John Libbey Eurotext - All rights reserved
[ Legal information - Powered by Dolomède ]